Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimal Treatment of Inflammation Following Acute Skeletal Muscle Injury

NCT06274151 is registered in ClinicalTrials.gov with Bispebjerg Hospital as lead sponsor.

NCT NCT06274151
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06274151 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimal Treatment of Inflammation Following Acute Skeletal Muscle Injury
Lead sponsor
Bispebjerg Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
February 15, 2024
Completion date
December 31, 2029
Enrollment
20 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

inflammation, muscle strain, multiple sites